Reckitt Benckiser Group PLC (OTCMKTS:RBGLY – Get Free Report) shares gapped up before the market opened on Wednesday. The stock had previously closed at $13.30, but opened at $13.64. Reckitt Benckiser Group shares last traded at $13.59, with a volume of 89,785 shares changing hands.
Analyst Ratings Changes
A number of brokerages have recently commented on RBGLY. Jefferies Financial Group raised Reckitt Benckiser Group from a “hold” rating to a “buy” rating in a research note on Tuesday, July 21st. Deutsche Bank Aktiengesellschaft restated a “hold” rating on shares of Reckitt Benckiser Group in a research note on Tuesday, June 30th. BNP Paribas Exane cut shares of Reckitt Benckiser Group from an “outperform” rating to a “neutral” rating in a research note on Wednesday, September 2nd. The Goldman Sachs Group upgraded Reckitt Benckiser Group to a “buy” rating in a research note on Wednesday. Finally, Zacks Research raised shares of Reckitt Benckiser Group from a “strong sell” rating to a “hold” rating in a research report on Friday, August 28th. Two investment analysts have rated the stock with a Strong Buy rating, four have given a Buy rating and four have given a Hold rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy”.
Read Our Latest Stock Report on Reckitt Benckiser Group
Reckitt Benckiser Group Stock Up 2.0%
Reckitt Benckiser Group Company Profile
Reckitt Benckiser Group plc, now known as Reckitt, is a United Kingdom-based consumer health and hygiene company headquartered in Slough, England. The company develops, manufactures and markets products intended to support personal health, household cleanliness and hygiene.
Its brand portfolio includes consumer health products such as Nurofen, Strepsils, Mucinex and Durex, as well as household and hygiene brands including Dettol, Lysol, Finish and Vanish. Reckitt’s products are sold through retailers, pharmacies, e-commerce platforms and other distribution channels.
The company was formed in 1999 through the merger of Reckitt & Colman and Benckiser.
See Also
- Five stocks we like better than Reckitt Benckiser Group
- DraftKings Stacks the Deck: The $800M Prediction Pivot
- Wall Street Is Betting These 3 Beaten-Down Stocks Have More Room to Run
- Marvell Technology’s $90 Billion Revenue Goal Puts AI Execution Under a Microscope
- Meta Enterprise Platform: The “Next Major Pillar” of Zuckerberg’s AI Vision
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.
